Clinical Trial Update: PIPAC for the Treatment of Colorectal Peritoneal Metastases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating PIPAC for treating colorectal peritoneal metastases conducted by Imperial College London.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Peritoneal Metastases

Drugs mentioned

• PIPAC (Pressurized intraperitoneal aerosol chemotherapy)

Snippet

Sponsor: Imperial College London | Conditions: Colorectal Neoplasms, Peritoneal Metastases | Phase 1, Phase 2 | Status: UNKNOWN